Avinger shares are trading higher after the company announced it will be issued the U.S. patent number 12,089,868 for the treatment of occlusive coronary artery disease.
Portfolio Pulse from Benzinga Newsdesk
Avinger shares rise following the announcement of a new U.S. patent issuance for the treatment of occlusive coronary artery disease.
September 16, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger shares increased after the company announced the issuance of a U.S. patent for a treatment related to occlusive coronary artery disease. This development could enhance Avinger's product offerings and market position.
The issuance of a new patent is a significant development for Avinger, as it could lead to new product offerings and strengthen its market position in the treatment of coronary artery disease. This news is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100